Treatment outcomes for breast cancer patients with previous augmentation mammoplasty
Abstract
Objective. To retrospectively analyse, using the institutional material of the N.N. Blokhin National Medical Research Center of Oncology, the distribution of surgical procedures, the complication rate and the quality of life (BREAST-Q questionnaire) in breast cancer patients with a history of augmentation mammoplasty, and to perform a preliminary comparison of the outcomes of breast-conserving surgery and subcutaneous mastectomy with immediate implant-based reconstruction. Materials and Methods. All patients treated at the N.N. Blokhin National Medical Research Center of Oncology between 2011 and 2025 were identified. All women in whom breast cancer was diagnosed after a previous augmentation mammoplasty were consecutively included, irrespective of the volume of augmentation, patient age at augmentation, implant type and time since the procedure. No exclusion criteria were applied. Patients were allocated to two main groups according to the extent of surgery — breast-conserving surgery without implant exchange and subcutaneous mastectomy with immediate implant-based reconstruction — and compared with respect to baseline clinicopathological characteristics and BREAST-Q domain scores. Results. A total of 24 patients were included. Subcutaneous mastectomy with immediate implant-based reconstruction was performed in 12 cases (50%), breast-conserving surgery without implant exchange in 8 cases (33%), radical mastectomy in 3 cases (13%), and subcutaneous mastectomy with skin envelope reduction and implant exchange in 1 case (4%). Complications occurred in 2 patients (8%). The two main groups were comparable with respect to baseline characteristics. Analysis of quality of life revealed no statistically significant differences between the breast-conserving surgery group (n = 6) and the subcutaneous mastectomy with immediate reconstruction group (n = 5) in any of the four BREAST-Q domains (all p 0.05). Conclusions. Subcutaneous mastectomy with immediate reimplantation of a larger-volume implant appears to be a technically feasible and potentially promising procedure in selected patients with early-stage breast cancer, as an alternative to sectoral resection, allowing the omission of adjuvant radiation therapy. Preliminary safety data from our series of 12 cases require further investigation in larger cohorts to evaluate long-term oncological and aesthetic outcomes.